tiprankstipranks
Trending News
More News >
Promising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements
PremiumRatingsPromising Potential of Sagimet Biosciences: Buy Rating Affirmed by Positive Phase 3 Trial Results and Strategic Advancements
26d ago
Sagimet Biosciences Announces Phase 3 Trial Success
Premium
Company Announcements
Sagimet Biosciences Announces Phase 3 Trial Success
26d ago
Sagimet Biosciences to host KOL event on denifanstat, resmetirom
Premium
The Fly
Sagimet Biosciences to host KOL event on denifanstat, resmetirom
1M ago
Sagimet Biosciences reports Q1 EPS (56c), consensus (69c)
PremiumThe FlySagimet Biosciences reports Q1 EPS (56c), consensus (69c)
2M ago
Sagimet Biosciences announces presentations at EASL Congress 2025
Premium
The Fly
Sagimet Biosciences announces presentations at EASL Congress 2025
2M ago
Sagimet Biosciences: Promising Future with Phase 3 MASH Trials and Strong Financial Position
Premium
Ratings
Sagimet Biosciences: Promising Future with Phase 3 MASH Trials and Strong Financial Position
4M ago
Promising Pipeline and Positive Trial Data Support Buy Rating for Sagimet Biosciences
PremiumRatingsPromising Pipeline and Positive Trial Data Support Buy Rating for Sagimet Biosciences
4M ago
Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567
Premium
Ratings
Sagimet Biosciences’ Strategic Expansion into Acne Treatment with Promising FASN Inhibitor TVB-3567
4M ago
Sagimet Biosciences announces clearance of IND for FASN inhibitor TVB-3567
Premium
The Fly
Sagimet Biosciences announces clearance of IND for FASN inhibitor TVB-3567
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100